|
|
開催概要 | Veeva Japan Clinical Summit
|
|
https://veeva.jp/event/veevaclinical2020/
|
|
|
|
|
|
Veeva Development Cloud: https://www.veeva.com/jp/products/development-cloud/
Vault Clinical: https://www.veeva.com/jp/products/vault-clinical/
Vault RIM: https://www.veeva.com/jp/products/vault-rim/
Vault Quality: https://www.veeva.com/jp/products/vault-quality/
Vault eTMF: https://www.veeva.com/jp/products/vault-etmf/
Vault CTMS: https://www.veeva.com/jp/products/vault-ctms/
Vault Submissions: https://www.veeva.com/jp/products/vault-submissions/
Vault Registrations: https://www.veeva.com/jp/products/vault-registrations/
Vault Submissions Archive: https://www.veeva.com/jp/products/vault-submissions-archive/
Vault QMS: https://www.veeva.com/jp/products/vault-qms/
Vault QualityDocs: https://www.veeva.com/jp/products/vault-qualitydocs/
2020 Veeva Japan Clinical Summit: https://veeva.jp/event/veevaclinical2020/
【Veeva Systems社について】
Veeva Systems社はグローバルなライフサイエンス企業向けにクラウドベースのソフトウェアを提供するリーディングカンパニーです。世界最大規模の製薬会社からバイオテクノロジー分野の新興企業まで、900社を超える顧客に技術革新への取り組みや卓越した製品力によって、お客様の成功にコミットする様々なサービスを提供しています。Veevaは、サンフランシスコのベイエリアに本社を置き、ヨーロッパ、アジア、ラテンアメリカに拠点を展開しています。
詳しくは、https://veeva.com/jp/をご覧ください。
【Forward-looking Statements】
This release contains forward-looking statements, including the market demand for and acceptance of Veeva’s products and services, the results from use of Veeva’s products and services, and general business conditions (including the on-going impact of COVID-19), particularly within the life sciences industry. Any forward-looking statements contained in this press release are based upon Veeva’s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent Veeva’s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and Veeva disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect Veeva’s financial results are included under the captions, “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” in the company’s filing on Form 10-Q for the period ended July 31, 2020. This is available on the company’s website at veeva.com under the Investors section and on the SEC’s website at sec.gov. Further information on potential risks that could affect actual results will be included in other filings Veeva makes with the SEC from time to time.